Abstract
Dyer and colleagues examine the most promising preclinical models that recapitulate the molecular, genetic, and cellular features of retinoblastoma.
MeSH terms
-
Animals
-
Antineoplastic Agents / pharmacology
-
Antineoplastic Agents / therapeutic use
-
Cell Death
-
Cell Proliferation
-
Clinical Trials as Topic
-
Disease Models, Animal*
-
Humans
-
Mice
-
Phenotype
-
Retinal Neoplasms / physiopathology*
-
Retinal Neoplasms / therapy*
-
Retinoblastoma / physiopathology*
-
Retinoblastoma / therapy*